DUALITY BIOLOGICS
โTo Translate Novel Modality into Realityโ. Duality Biologics was founded in January 2020 by Dr. John Zhu, a well-respected investor in the healthcare industry. Duality Bio is committed to developing novel modality drugs to fulfill the unmet medical needs for patients worldwide. Focusing on the oncology and autoimmune diseases, the company has built a novel internal pipeline including nearly 10 Best-in-Class and First-in-Class bispecific antibody and Antibody-Drug Conjugate (ADC) drugs, of which several drug candidates are in the IND stage. The company has successfully built the next-generation ADC platform with global intellectual property rights. The value of this platform has been validated by a number of drug candidates under development.
DUALITY BIOLOGICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2020-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.dualitybiologics.com
Total Employee:
11+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
90 M USD
Similar Organizations
Dare Bioscience
Darรฉ Bioscience is a healthcare company committed to the development and commercialization of innovative products.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
OnQuality Pharmaceuticals
OnQuality Pharmaceuticals involves in development and commercialization of innovative drugs and drug delivery systems.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Employees Featured
Founder
Investors List
Oriza Holdings
Oriza Holdings investment in Series B - Duality Biologics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Duality Biologics
Huagai Capital
Huagai Capital investment in Series B - Duality Biologics
WuXi Biologics
WuXi Biologics investment in Series B - Duality Biologics
Green Pine Capital Partners
Green Pine Capital Partners investment in Series B - Duality Biologics
NRL Capital
NRL Capital investment in Series B - Duality Biologics
Official Site Inspections
http://www.dualitybiologics.com
- Host name: 223.166.75.128
- IP address: 223.166.75.128
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai